Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Patients with alopecia areata feel less regret about treatment decisions when they are involved in the decision-making process.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

A patient with complete hair loss regrew all her hair using tofacitinib.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Tofacitinib treatment for hair loss may worsen acne.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

Online articles about alopecia areata are too hard to understand and need to be clearer.

Tofacitinib can cause a rare rash called SDRIFE, which resolves after stopping the drug.

JAK inhibitors may effectively treat lichen planopilaris and frontal fibrosing alopecia with minimal side effects.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

Topical tofacitinib shows promise as a future treatment for alopecia areata.

Beard alopecia areata causes patchy beard hair loss, often treatable with janus kinase inhibitors.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Tofacitinib can help hair grow back in alopecia patients but hair loss might return if the dose is lowered.